Evidence map›Paper›PMID 27820807›Full record

ArticleNature structural & molecular biology2016

The ribosome-engaged landscape of alternative splicing.

Robert J Weatheritt, Timothy Sterne-Weiler, Benjamin J Blencowe

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome.Journal of cardiovascular development and disease · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Impact of alternative splicing on Arabidopsis proteome.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Perplexity as a Metric for Isoform Diversity in the Human Transcriptome.bioRxiv : the preprint server for biology · 2025
    Article
  17. Mechanisms suppressing noncoding translation.Trends in cell biology · 2025
    Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Robert J WeatherittDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Timothy Sterne-WeilerDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Benjamin J BlencoweDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CA

Funding

Biotechnology and Biological Sciences Research Council BB/I004718/1Medical Research Council MC_U105185859
6 · The paper itself

Abstract

High-throughput RNA sequencing (RNA-seq) has revealed an enormous complexity of alternative splicing (AS) across diverse cell and tissue types. However, it is currently unknown to what extent repertoires of splice-variant transcripts are translated into protein products. Here, we surveyed AS events engaged by the ribosome. Notably, at least 75% of human exon-skipping events detected in transcripts with medium-to-high abundance in RNA-seq data were also detected in ribosome profiling data. Furthermore, relatively small subsets of functionally related splice variants are engaged by ribosomes at levels that do not reflect their absolute abundance, thus indicating a role for AS in modulating translational output. This mode of regulation is associated with control of the mammalian cell cycle. Our results thus suggest that a major fraction of splice variants is translated and that specific cellular functions including cell-cycle control are subject to AS-dependent modulation of translation output.

Indexed as

5' Untranslated RegionsAlternative SplicingAnimalsCell CycleGenomicsHigh-Throughput Nucleotide SequencingHumansIntronsMiceRibosomesRNA, MessengerRNA, RibosomalSequence Analysis, RNA5' Untranslated RegionsRNA, MessengerRNA, Ribosomal

Identifiers

PMID27820807
PMCPMC5295628
OpenAlexW2554777987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.